Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05605145

PCP in Immunocompromised Population in Southern China

Conditions: Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis, Polymerase Chain Reaction

Sex: All
Enrollment: 300
Sponsor: First Affiliated Hospital of Guangxi Medical University

Location: China

Summary

To evaluate the sensitivity and specificity of the combined detection system for the diagnosis of pneumocystis infection in immunocompromised population in Southern China.

Eligibility Criteria

Inclusion Criteria:Patients with immunocompromised conditions, including but not limited to HIV infection, long-term systemic use of corticosteroids, use of immunosuppressive agents, hematologic malignancies, solid tumors, hematopoietic stem cell transplantation, solid organ transplantation, radiotherapy and/or chemotherapy for malignancies,primary immunodeficiency disease.Patients with typical clinical manifestations of PJP such as fever,nonproductive cough, shortness of breath, and progressive hypoxemia.Patients with radiological abnormalities suggestive to PJP in bilateral lungs revealed by chest computed tomography (CT).Respiratory tract samples were collected for qPCR and/or mNGS detection.Exclusion Criteria:Patients who were unable to obtain a respiratory specimen.Medical record was incomplete.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05605145). StuddyBuddy aggregates publicly available trial information.